RxDoctor Payments Data

Meaghan Canton-Feder, NP

Licensed Practical Nurse · Chevy Chase, MDNPI 1144401571

Payments from drug & device makers

$3,033in general payments, 2019–2025

Across 132 payments — averaging $22.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$735
  • Incyte Corporation$449
  • Sun Pharmaceutical Industries Inc.$339
  • Sanofi$287
  • AbbVie$198
  • Arcutis Biotherapeutics, Inc.$147
  • plus $878 from 15 others

What the payments were for

  • Food & beverage$2,81893%
  • Education$2147%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few licensed practical nurse providers in Marylandto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$4,097
Medicare patients
14
Services billed
58

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JubliaEfinaconazole19$16,805
Tacrolimus16$1,887
Clobetasol Propionate22$1,703
Fluorouracil15$831
Econazole Nitrate16$747
Ketoconazole51$616
Triamcinolone Acetonide47$341
Nystatin13$309
Mupirocin24$186

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Ortho Dermatologics, A Division Of Bausch Health US, LLCJublia$106$16,80519 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few licensed practical nurse providers in Marylandon file to place this against a meaningful peer group, so we don't.

Other licensed practical nurse in Chevy Chase

Where these figures come from

Is this you, or does something look wrong? →